Fiona Eatock, President BAETS
Marcin Barczyński, President PCES

1. • Katarzyna Ziemnicka (Poznań, PL): Active Surveillance for Papillary Thyroid Microcarcinoma (15 min)
   • George Mochloulis (Stevenage, UK): Thermal Ablation for Papillary Thyroid Microcarcinoma (15 min)
   • Iain Nixon (Edinburgh, UK): Surgery for low-risk DTC (15 min) 
   • Agnieszka Czarniecka (Gliwice, PL): Management of intermediate-risk DTC (15 min)
   • Marek Dedecjus (Warsaw, PL): Management of advanced DTC (15 min)

• Kwapisz M, DlugosinskaJ, Januszkiewicz-Caulier J, Dworakowska A, Galczynski J, Góralski P, Gorzelnik A, Dedecjus M (Warsaw, PL): Tracheostomy for airway compromise in anaplastic thyroid carcinoma: Survival outcomes and clinical utility in a single-centre retrospective cohort. (Abstract ID: 111)
• Budzynska M, Gajoch I,, Krakowska K, Konturek A, Barczynski M (Kraków, PL): Beyond thyroidectomy: Gut microbiota changes during differentiated thyroid cancer treatment – a systematic review. (Abstract ID: 113)
• Budzynska M, Krakowska K, Konturek A, Barczynski M (Kraków, PL): Thermal ablation for Bethesda III-IV thyroid nodules: Is the current level of evidence sufficient to justify changes in clinical practice? (Abstract ID: 118)

1. • Susannah Shore (Liverpool, UK) How to assess risk of malignancy? (15 min)
   • Aleksandra Gilis-Januszewska (Kraków, PL) How to define and manage mild autonomous cortisol secretion (MACS)? (15 min)
   • Piotr Myśliwiec (Białystok, PL) Who should have surgical treatment and how should it be performed? (15 min)
   • Peter Truran (Newcastle, UK) What follow-up is indicated if the adrenal incidentaloma is not surgically removed? (15 min)

• Kurzawinski TR, Sanders K, Chung TT, Abdel-Aziz T, Rosalen-Garcia V, Bosch K, Mihai R, Dickinson L, Anderson C, Arstad E, Buhidma Y, Awais RO, Sirindil F, Shortman R, O'Keeffe AG, Dickson J, Brown MJ, Williams B (London, Nottingham, Oxford, UK): Adrenal Aldosterone Synthase Expression Imaging with ¹⁸FAldoView correctly predicts lateralisation of abnormal Aldosterone secretion in patients with Primary Aldosteronism. (Abstract ID: 65)
• Vanalia P, Costa Silva A, Safwaan A, Ho J, Gulamhusein A (Manchester, UK): Day-Case Robotic Adrenalectomy Within An Enhanced Recovery Programme: A Single Centre Experience. (Abstract ID: 83)
• Parikh RP, Bosch KB, Khan SK, Mihai RM (Oxford, UK): Can Robotic Adrenalectomy Improve Service Delivery? (Abstract ID: 51)

• Xu N, Khoo R, Occhiuzzi F, Latella D, Volpini L (Blackpool, Southampton, UK; Catanzaro, IT): Evaluation of the effect of Intra-operative Tranexamic Acid in Thyroid Surgery - A systematic Review and Meta-analysis. (Abstract ID: 1)
• Baig H, Khan Q, Shah F, Lucocq J, Watson C (Glasgow, Aberdeen, UK): Botulinum Toxin A for Improving Anterior Neck Scar Outcomes After Thyroid and Parathyroid Surgery: A Systematic Review. (Abstract ID: 74)
• Choi K, Kim SK, Lee YM (Seoul, KR): Comparison of single-port robotic and laparoscopic posterior retroperitoneal adrenalectomy: the shifting impact of tumor size on operative efficiency. (Abstract ID: 33)
• Iscan Y, Karatas I, Sormaz IC, Aksakal N, Tunca F, Senyurek Y (Istanbul, TR): Continuous Versus Intermittent Intraoperative Neuromonitoring in Thyroid Surgery: A Single-Center Analysis of 4,008 Nerves at Risk. (Abstract ID: 131)
• Watts E, Chander N, BAETS Collaborative Authorship, Sharma N (Birmingham, London, UK): Peri-Operative Management of Graves’ Disease Undergoing Total Thyroidectomy: A National BAETS Survey of UK Practice. (Abstract ID: 4)
• Abdelsalam A, Eddama M, Rozalin-Garcia V, Kurzawinski T, Abdel-Aziz T (London, UK): Clinical Improvement After Adrenalectomy for Primary Aldosteronism: External Validation of the PADSS Score. (Abstract ID: 12)
• Bosch KD, Parikh R, Lau J, Fraser SM, Mihai R, Khan S, De Jong MC (Oxford, Leeds, UK): Adrenalectomy in the Elderly: Increased Frailty Without Worse Outcomes. (Abstract ID: 92)
• Agilinko JA, Bawa JH, Moonim MT, Tolley NS, Palazzo FF, Jarvis S, Bevan CL, Di Marco AN (London, UK): Beyond Diagnostic Accuracy: Are Molecular Classifiers Clinically Interchangeable? Insights from Hierarchical Meta-analysis and Computational Outcome Modelling in 4,377 Indeterminate Thyroid Nodules. (Abstract ID: 107)
• Ahmad H, MacFaul W, Stechman M, Scott-Coombes D, Patel N (Cardiff ,UK): Parathyroidectomy with intraoperative PTH for Primary hyperparathyroidism: A single centre 10 year follow up experience. (Abstract ID: 66)

• Michał Kusiński (Łódź, Poland): Alternative access for retroperitoneal paraganglioma as a good operative option. (Abstract ID: 96)
• Joel Smith (Exeter, UK): Transoral Robotic Resection of retorpharyngeal PTC node. (Abstract ID: 139)
• Parthvi Vanalia (Manchester, UK):Robotic Excision of a Paraganglioma Using a Supine Approach: Technical Nuances and Advantages. (Abstract ID: 84)
• Beata Wojtczak (Wrocław, Poland): Intraoperative neuromonitoring in recurrent goitre. (Abstract ID: 91)

We invite you to a hands-on practical workshop on laser thermal ablation of thyroid lesions using the Echolaser system and ModiLite application.

The workshop will be conducted at two fully equipped workstations, each featuring an Echolaser system with ultrasound and dedicated neck phantoms containing simulated thyroid nodules. Participants will have the opportunity to learn the principles of the procedure and perform a simulated laser thermal ablation, using ModiLite for procedure planning and guidance.

Each participant will have approximately 30 minutes of hands-on training at the workstation. The workshop is designed for a total of 24 participants.

The workshop will be led by experienced specialists who provide regular training in the use of Echolaser for thyroid procedures. Approximately 1,200 thyroid laser thermal ablation procedures are performed annually in Poland, and our specialists train new physicians every month. Following practical training, physicians are able to progress rapidly towards performing laser thermal ablation procedures independently using the Echolaser system.

Limited capacity – 24 participants

Registration for the workshops via email at: k.paszkowska@sympomed.pl

• Nikita Chander (London, UK) Welcome and introduction (3 min)
• Nikita Chander (London, UK), Emma Watts (Birmingham, UK): BAETS Trainee Update (7 min)

BAETS Trainee Oral Presentations:

• MacFaul W, Sabah Y, Sinclair J, Patel N, Scott-Coombes D, Puttergill B, Stechman M (Cardiff, Buckinghamshire, UK):  Outcomes of Adrenalectomy for mild autonomous cortisol secretion in a UK tertiary endocrine surgery centre.
  (Abstract ID: 108)
• Alhazzaa N, Rozalen-Garcia V, Abdel-Aziz T, Zielke A, Schaffer K, Recasens-Subias M, Garcia-Barasa A, Moreno-Llorente P, Smaxwill CA, Kurzawinski TR (London, UK): Prognostic value of Point of Care PTH measurements in predicting hypocalcaemia on the 1st day after Total Thyroidectomy. Multicentre, Prospective, Single Arm, Observational Study.
  (Abstract ID: 25)
• Watts E, Butler S, Colley K, Boelaert K, Sharma N (Birmingham, UK): Diagnostic Performance of the British Thyroid Association U Classification: A Systematic Review and Meta-Analysis.
  (Abstract ID: 5).
• Polak Z, Kolodziejska K, Kolasa J, Zarychta S, Proniewska van Dam K, Konturek A, Barczynski M (Krakow, PL): Mixed reality-assisted patient-specific 3D modelling for preoperative planning in complex thyroid surgery: A prospective pilot study
  (Abstract ID: 45)

• Richard Egan (Cowbridge, UK): General Surgery SAC Update (5 min)
• Omar Hilmi (Glasgow, UK): ENT SAC Update (5 min)
• Emma Watts (Birmingham, UK): BAETS Travelling Fellowship (5 min)
• Nikita Chander (London, UK): Closing remarks (5 min)

Speakers:

• Witold Chudziński (Warsaw, PL) Diagnosis of Primary Hyperparathyroidism – Redefining Biochemical and Clinical Boundaries (10 min)
• Małgorzata Trofimiuk-Müldner (Kraków, PL) Preoperative localization in PHPT (10 min)
• Neil Sharma (Birmingham, UK) Surgical Management – Who Should Be Operated and When? (10 min)
• Alicja Hubalewska-Dydejczyk (Kraków, PL) Non-Surgical Management – Medical Therapy vs Thermal Ablation vs Active Surveillance (10 min)
• Neil Gittoes (Birmingham, UK) Long-Term Outcomes – What Do We Know and What Remains Unclear? (10 min)
• Discussion (10 min)

• Gittoes N, Palermo A, Rejnmark L, Khan A, Schwarz P, Hofbauer L, Cetani F, Jain R, Clarke B, Zhao C, Shu A, Rubin M (Birmingham, UK; Rome, IT; Aarhus, DK; Hamilton, CA; Copenhagen, DK; Dresden, DE; Pisa, IT; Chicago, New Yok, USA): Five-Year Data Report From the Phase 2 PaTH Forward Trial of Palopegteriparatide for Adults With Hypoparathyroidism. (Abstract ID: 11)
• Gawrychowska-Janicka A, Bronikowska J, Czuba Z, Gawrychowski J (Zabrze, PL): The effect of vitamin D3 on proinflammatory cytokines in women with primary hyperparathyroidism before and after parathyroidectomy (PTX). (Abstract ID: 59)
• Sadiq AA, Zammit C (Brighton, UK): A systematic review assessing long-term health-related quality of life after parathyroidectomy in patients with primary hyperparathyroidism. (Abstract ID: 42)

Medtronic Sponsored Session

Inomed Sponsored Lecture

Quan Yang-Duh (San Francisco, USA)

Introduction: Marcin Barczynski (Kraków, PL)

• Barczyński M, Kołodziejska K, Krakowska K, Dworak M, Konturek A (Kraków, PL): Low dose indocyanine green probe-based quantification of parathyroid vascularity: A comparative study with standard dose camera-based fluorescence angiography. (Abstract ID: 44)
• Patel AP, Janicki JL, Rostkowska OR, Śledziński MS, Hellmann AH (Gdańsk, PL): Neuromuscular blockade protocol for effective intraoperative neuromonitoring in thyroid surgery: a systematic review. (Abstract ID: 22)
• Krakowska K, Krężołek M, Kulesa-Mrowiecka M, Konturek A, Barczyński M (Kraków, PL): Postoperative changes in muscle stiffness and quality of life after thyroid and/or parathyroid surgery: A pilot study. (Abstract ID: 68)

• Neil Gittoes (Birmingham, UK): Opening remarks (5 min)
• Shad Khan (Oxford, UK): The Patients We Cure. The Condition We Cause. Post-Surgical Chronic Hypoparathyroidism (10 min)
• Neil Gittoes (Birmingham, UK): Chronic Hypoparathyroidism: Are We Addressing the Underlying Problem? (10 min)
• Neil Gittoes (Birmingham, UK), Shad Khan (Oxford, UK): Q&A (5 min)

Objectives:

• Recognise the long-term clinical and quality of life impact of post-surgical chronic hypoparathyroidism
• Explore the ongoing challenges associated with chronic hypoparathyroidism and its management
• Evaluate the role of PTH replacement therapy with Yorvipath^® (palopegteriparatide) in addressing unmet treatment needs

Faculty:

• Professor Neil Gittoes (Chair), Head of Centre for Endocrinology, Diabetes and Metabolism, Consultant Endocrinologist and Honorary Professor of Endocrinology, University of Birmingham
• Mr Shad Khan, Consultant Endocrine and General Surgeon, Oxford University Hospital

Yorvipath^® is not currently available in Poland.¹

1. European Medicines Agency (EMA), Yorvipath Summary of Product Characteristics (SmPC). Available at: https://www.ema.europa.eu/en/documents/product-information/yorvipath-epar-product-information_en.pdf. Accessed September 2026.
This promotional meeting is organised and funded by Ascendis Pharma for healthcare professional (HCPs) only. Product-related information will be discussed in this meeting.
Ascendis^®, Ascendis Pharma^®, the Ascendis Pharma logo, the company logo and Yorvipath^® are trademarks owned by the Ascendis Pharma Group.
© September 2026 Ascendis Pharma UK Limited.
UK-COMMPTH-2600101 | September 2026

• Gkrinia E, Karamitsou P, Brown J, Gagen H, Rajaguru K, Mochloulis G, Dimitriadis P (Stevenage, UK): Thermal Ablation of Benign Thyroid Nodules: The Lister Hospital Experience. (Abstract ID: 64)
• Morales D, Fernandez JL, Soler R, Bregoli N, Dominguez MD, Monje C, Perez L, Plata G, Peix M, Ocana LT (Malaga, Spain): Prophylactic Central Lymph Node Dissection in Patients with Bethesda V FNA: Discussion is Opened. (Abstract ID: 34)
• O'Brien AOB, Ionescu AI, Sheahan PS (Cork, Ireland): Intraoperative Autofluorescence Imaging for Parathyroid Preservation in Total Thyroidectomy: A Retrospective Analysis. (abstract ID: 43)

Speakers:

• Case 1: Beata Kos-Kudła (Katowice, PL)
• Case 2: Tarek Abdul-Aziz (London, UK)
• Case 3: Ewelina Rzepka (Kraków, PL)
• Case 4: Tom Kurzawinski (London, UK)

Speakers:

• James Kirkby-Bott (Southampton, UK), Sid Nagala (Reading, UK): Artificial Intelligence in Endocrine Surgery: From Decision Support to Autonomous Systems (12 min)
• Klaudia Proniewska-van Dam (Krakow, PL): High‑resolution 3D visualization of endocrine organs with emphasis on thyroid, parathyroid, and adrenal tumors—a new platform for medical education, mixed/virtual reality, and computational simulation (12min)
• Marco Raffaelli (Rome, IT): Simulation-Based Training in Endocrine Surgery: Current Standards and Future Directions (12 min)
• Özer Makay (Izmir, TR): Educational Strategies for TOETVA and Robotic Thyroidectomy: Building Competence in Novel Approaches (12 min)
• Discussion (12 min)

Fiona Eatock, President BAETS
Marcin Barczyński, President PCES